BKV Amplification Oligonucleotides for Low-Copy Viral Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and quantifying human polyomavirus BK virus (BKV) are not sensitive enough to accurately identify low levels of the virus in samples, particularly in immunosuppressed patients, leading to potential complications such as BKV-associated nephropathy and graft loss in transplant recipients.
Innovation Solution
The development of amplification oligonucleotides, including primers and probe oligonucleotides, that specifically target BKV sequences, allowing for sensitive detection and quantification using various nucleic acid amplification methods, including PCR and isothermal techniques, with modifications to enhance stability and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current detection methods are used, then the detection process is simple, but the sensitivity is insufficient to accurately identify low levels of BKV
Solution Approach 1:
The detection method is divided into multiple sequential steps: nucleic acid extraction, amplification using specific primers, and detection using labeled probes. This segmentation allows each step to be optimized independently, achieving high sensitivity through the combination of amplification and specific probe detection while maintaining procedural simplicity.
Solution Approach 2:
Labeled probes serve as intermediaries that specifically bind to amplified BKV nucleic acid sequences. These probes carry detectable labels (fluorescent, enzymatic, or radioactive) that enable sensitive detection of the amplified target, bridging the gap between amplification and detection while significantly enhancing detection sensitivity.
2Measurement precision
If amplification oligonucleotides are used to enhance sensitivity, then detection sensitivity improves, but the risk of false positives increases
Solution Approach 1:
The primers and probes are designed with high sequence specificity targeting unique regions of the BKV genome. By optimizing the local sequence characteristics (melting temperature, GC content, and sequence complementarity), the method achieves high sensitivity while maintaining specificity, as the labeled probes only bind to their exact complementary sequences during detection.
Solution Approach 2:
The detection system incorporates feedback mechanisms where the labeled probes provide real-time detection signals during amplification. This allows for monitoring of amplification progress and confirmation of specific binding, enabling differentiation between true positive signals and non-specific amplification artifacts, thus maintaining reliability while achieving high sensitivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described methods enable rapid, direct, and specific detection of BKV, even at low copy numbers, aiding in the management of transplant patients and assessing viral response to treatment, thereby reducing the risk of complications.
Implementation Method 1
The amplification oligonucleotides include amplification primers (first amplification primers and second amplification primers or first primers and second primers). The amplification oligonucleotides further include probe oligonucleotides that facilitate detection of amplified sequence.
Implementation Method 2
The nucleic acid amplification methods can use thermal cycling, or they can be isothermal.
Implementation Method 3
nucleic acid amplification methods known in the art include, but are not limited to, polymerase chain reaction (PCR), reverse transcriptase PCR (RT-PCR), real time PCR
Data Source
AI summary
Oligomer nucleotides, compositions, methods, kits, and uses are provided for detecting or quantifying a human polyomavirus BK virus (BKV) nucleic acid, e.g., using nucleic acid amplification and hybridization assays.